Clinical Trials Browser

Phase 2 × Head and Neck Neoplasms × Megestrol Acetate × Clear all

NCT02980653 2017-01-18

Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT

Phase 2 Unknown

Head and Neck Neoplasms